Cargando…

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU

Mostrar otras versiones (1)

δ opioid receptor (DOR) was the first opioid receptor of the G protein-coupled receptor family to be cloned. Our previous studies demonstrated that DOR is involved in regulating the development and progression of human hepatocellular carcinoma (HCC), and is involved in the regulation of the processe...

Descripción completa

Detalles Bibliográficos
Autores principales:	TANG, BO, HU, ZHIGAO, LI, YANG, YUAN, SHENGGUANG, WANG, ZHENRAN, YU, SHUIPING, HE, SONGQING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686084/ https://www.ncbi.nlm.nih.gov/pubmed/26549838 http://dx.doi.org/10.3892/mmr.2015.4511

Ejemplares similares

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU
por: Tang, Bo, et al.
Publicado: (2018)

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU
por: Tang, Bo, et al.
Publicado: (2023)

The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells
por: Yuan, Falu, et al.
Publicado: (2016)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression
por: Tang, Bo, et al.
Publicado: (2016)

Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling
por: Tang, Bo, et al.
Publicado: (2016)

Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo
por: Tang, Bo, et al.
Publicado: (2023)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Whole transcriptome sequence data of 5-FU sensitive and 5-FU resistant tumors generated in a mouse model of de novo carcinogenesis
por: Iacovides, Demetris, et al.
Publicado: (2018)

5-FU blocks shuttling of HuR mediated by PKCδ in gastric cancer cells
por: Wu, Wenzhi, et al.
Publicado: (2020)

5-FU toxicity and nutritional deficiencies.
por: Stenram, U.
Publicado: (1993)

FuSuMaTech workshop
por: Olofsson, Simon
Publicado: (2018)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Disulfiram Enhances the Antineoplastic Activity and Sensitivity of Murine Hepatocellular Carcinoma to 5-FU via Redox Management
por: Hassan, Iftekhar, et al.
Publicado: (2023)

Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle
por: Tang, Bo, et al.
Publicado: (2016)

HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
por: Nagaraju, Ganji Purnachandra, et al.
Publicado: (2014)

The FU gene and its possible protein isoforms
por: Østerlund, Torben, et al.
Publicado: (2004)

George Fu Gao: the past and future of Ebola
por: Poo, Mu-ming, et al.
Publicado: (2015)

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.
por: Fleming, R. A., et al.
Publicado: (1992)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

Relationship Between Female Hormonal and Menstrual Factors and Pancreatic Cancer: A Meta-Analysis of Observational Studies
por: Tang, Bo, et al.
Publicado: (2015)

Transcriptomic and network pharmacology approaches revealed possible mechanisms underlying the 5-fluorouracil (5-FU)-sensitizing effect of Xuan-Fu-Hua decoction treatment on liver cancer cells
por: Luo, Wen-Zhao, et al.
Publicado: (2022)

Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells
por: Kim, Sung-Hee, et al.
Publicado: (2017)

JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2015)

Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2020)

El ciruelo de Yuan Pei Fu : poemas chinos
por: Pedroso, Regino 1898-
Publicado: (1955)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

5FU encapsulated polyglycerol sebacate nanoparticles as anti-cancer drug carriers
por: Sivanesan, Divya, et al.
Publicado: (2021)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

Mayfield-Tyzzer Hospital for Men at Laichon Fu, China
por: Gaston, J. M.
Publicado: (1911)

The fusion–fission optimization (FuFiO) algorithm
por: Nouhi, Behnaz, et al.
Publicado: (2022)

Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
por: Gonçalves-Ribeiro, Samuel, et al.
Publicado: (2016)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2021)

NDRG4 sensitizes CRC cells to 5-FU by upregulating DDIT3 expression
por: Li, Ruikai, et al.
Publicado: (2022)

miR-30a attenuates drug sensitivity to 5-FU by modulating cell proliferation possibly by downregulating cyclin E2 in oral squamous cell carcinoma
por: Kawahara, Kenta, et al.
Publicado: (2021)

nal‐IRI+5‐FU/LV versus 5‐FU/LV in post‐gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients
por: Ueno, Makoto, et al.
Publicado: (2020)

Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
por: Buhl, Ida Kappel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4sjstp8q1ua5pusupvpucss06b